Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$128M |
| 2 |
FedEx
FDX
|
+$120M |
| 3 |
Peloton Interactive
PTON
|
+$97.8M |
| 4 |
Newmont
NEM
|
+$78.9M |
| 5 |
Infosys
INFY
|
+$78.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$291M |
| 3 |
Apple
AAPL
|
+$261M |
| 4 |
Microsoft
MSFT
|
+$240M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.85% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 14.74% |
| 4 | Consumer Staples | 10.36% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HAPN
2126
Happen Inc
HAPN
$2.13B
| $143K | ﹤0.01% |
13,552
| – | – |
|
2127
Vitamin Cottage Natural Grocers
NGVC
$637M
| $143K | ﹤0.01% |
10,375
| – | – |
|
2128
KALA BIO
KALA
$15.9M
| $138K | ﹤0.01% |
8
-6
| -43% | -$113K |
|
2129
Liberty Energy
LBRT
$3.16B
| $138K | ﹤0.01% |
+13,400
| New | +$122K |
|
2130
RPC Inc
RES
$1.41B
| $138K | ﹤0.01% |
43,652
+5,006
| +13% | +$15K |
|
|
TPCO
2131
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $138K | ﹤0.01% |
10,081
-9,339
| -48% | -$115K |
|
|
ATHX
2132
DELISTED
Athersys, Inc. Common Stock
ATHX
| $135K | ﹤0.01% |
3,094
-636
| -17% | -$28.9K |
|
2133
LiveOne
LVO
$54.4M
| $134K | ﹤0.01% |
4,084
-5,608
| -58% | -$137K |
|
|
LITS
2134
Lite Strategy Inc
LITS
$33.7M
| $131K | ﹤0.01% |
2,481
| – | – |
|
|
EXPR
2135
DELISTED
Express, Inc.
EXPR
| $130K | ﹤0.01% |
+7,133
| New | +$135K |
|
|
KZR
2136
DELISTED
Kezar Life Sciences
KZR
| $129K | ﹤0.01% |
+2,477
| New | +$138K |
|
2137
Fennec Pharmaceuticals
FENC
$396M
| $124K | ﹤0.01% |
16,591
-5,168
| -24% | -$39.4K |
|
|
HONE
2138
DELISTED
HarborOne Bancorp
HONE
| $124K | ﹤0.01% |
+11,434
| New | +$113K |
|
|
LCI
2139
DELISTED
Lannett Company, Inc.
LCI
| $124K | ﹤0.01% |
4,763
-37,063
| -89% | -$968K |
|
2140
Matrix Service
MTRX
$311M
| $123K | ﹤0.01% |
11,122
-79,633
| -88% | -$734K |
|
2141
Coty
COTY
$2.41B
| $122K | ﹤0.01% |
+17,464
| New | +$90K |
|
2142
Oceaneering
OII
$5.28B
| $117K | ﹤0.01% |
14,695
-7,723
| -34% | -$45.1K |
|
2143
Cadiz
CDZI
$310M
| $116K | ﹤0.01% |
10,859
| – | – |
|
2144
Kinross Gold
KGC
$38.9B
| $116K | ﹤0.01% |
15,816
-3,036
| -16% | -$24.2K |
|
2145
National CineMedia
NCMI
$239M
| $115K | ﹤0.01% |
3,103
-8,436
| -73% | -$256K |
|
|
SLNO
2146
DELISTED
Soleno Therapeutics
SLNO
| $114K | ﹤0.01% |
3,929
-2,976
| -43% | -$85.9K |
|
2147
Goldgroup Mining
GORO
$240M
| $112K | ﹤0.01% |
38,471
-8,241
| -18% | -$25.6K |
|
|
AGEN
2148
Agenus
AGEN
$364M
| $108K | ﹤0.01% |
1,726
-1,914
| -53% | -$142K |
|
2149
Cerus
CERS
$566M
| $108K | ﹤0.01% |
15,656
| – | – |
|
2150
Aquestive Therapeutics
AQST
$585M
| $106K | ﹤0.01% |
19,786
+776
| +4% | +$4.65K |
|
Similar funds
Cliff Asness's Q4 2020 Portfolio in Review
As of Q4 2020, Cliff Asness held 2,327 positions worth $56.4B, down 4.7% from $59.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cliff Asness withdrew a net $9.06B in Q4 2020, closing 151 positions and reducing 1,279 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cliff Asness opened a new position in Peloton Interactive worth $122M.
- Cliff Asness's largest Q4 2020 buy was Peloton Interactive: 803,242 shares worth $122M.
- Cliff Asness added most to Zoom in Q4 2020, an estimated $128M increase.
- Cliff Asness's biggest Q4 2020 reduction was Biogen, cutting an estimated $309M.
- Cliff Asness fully exited iShares Core S&P 500 ETF in Q4 2020, selling an estimated $291M.
- Cliff Asness's ten largest holdings make up 19% of its $56.4B portfolio in Q4 2020.
- Cliff Asness opened 157 new positions and closed 151 in Q4 2020.
- Cliff Asness's portfolio value fell 4.7% quarter-over-quarter to $56.4B.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.